Clinical Research Directory
Browse clinical research sites, groups, and studies.
5 clinical studies listed.
Filters:
Tundra lists 5 Chemotherapy-induced Thrombocytopenia clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT03937154
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer, or breast cancer measured by the ability to administer on-time, full-dose chemotherapy
Gender: All
Ages: 18 Years - 100 Years
Updated: 2026-04-07
39 states
NCT07063225
Romiplostim N01 for Chemotherapy-induced Thrombocytopenia
To evaluate the efficacy and safety of Romiplostim N01 to treat chemotherapy-induced thrombocytopenia in tumors
Gender: All
Ages: 18 Years - Any
Updated: 2025-07-14
1 state
NCT04600960
Eltrombopag for Chemotherapy-induced Thrombocytopenia
To evaluate the efficacy and safety of eltrombopag to treat chemotherapy-induced thrombocytopenia in solid tumors
Gender: All
Ages: 18 Years - Any
Updated: 2025-02-24
1 state
NCT05236582
Herombopag for Chemotherapy-induced Thrombocytopenia
To evaluate the efficacy and safety of Herombopag to treat chemotherapy-induced thrombocytopenia in Solid Tumors
Gender: All
Ages: 18 Years - Any
Updated: 2025-02-24
1 state
NCT05218226
Avatrombopag for Chemotherapy-induced Thrombocytopenia
To evaluate the efficacy and safety of Avatrombopag to treat chemotherapy-induced thrombocytopenia in solid tumors
Gender: All
Ages: 18 Years - Any
Updated: 2025-02-24
1 state